Parabilis Medicines, Inc.
PBLSNASDAQHealthcareBiotechnology
Latest quote
$39.31
−$0.22 · -0.56%
Aug 21, 3:55 PM ET
PBLS company overview
Regular session · ET · Market data may be delayed.
Company profile
Company websiteFog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Mathai Mammen
- Listed since
- Jun 10, 2026
- Employees
- 145
Market position
- Volume
- 354.61K
- 0.53× average
- Average volume
- 665.84K
- Average daily volume
- Market cap
- 4.59B USD
- Beta
- 0
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 71.45M USD
- P/E (TTM)
- -1.07×
- P/B (TTM)
- 1.09×
- P/S (TTM)
- 30,999.87×
- EV / EBITDA
- -0.5×
- Earnings yield
- -360.54%
- Free cash flow yield
- -306.50%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 100.00%
- Operating margin
- -66445.27%
- Net margin
- -66066.89%
- Return on equity
- 882.89%
- Return on assets
- -180.51%
- Return on invested capital
- -338.57%
Financial health
- Debt / equity
- 0.05×
- Current ratio
- 0.52×
Financial statements
Income trends
Operating income
−152.08M USD-20.58%
Net income
−145.89M USD-23.72%
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Research and development | 125.58M USD | 100.83M USD |
| Selling, general, and administrative | 26.5M USD | 25.3M USD |
| Operating expenses | 152.08M USD | 126.13M USD |
| Interest income | 3.39M USD | 6.41M USD |
| Interest expense | 1.52M USD | 1.49M USD |
| Depreciation and amortization | 2.5M USD | 2.1M USD |
| Operating income | −152.08M USD | −126.13M USD |
| Net income | −145.89M USD | −117.91M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 0%
- 0 beats, 1 miss, 0 met estimates
- Average EPS surprise
- -1306.06%
- 1 comparable report
- Latest EPS result
- -2.32
- Estimate -0.17 · Miss by 1306.06%
EPS: actual versus estimate
Recent quarterly results
ActualEstimate
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$40.00
1.63% upsidePast 12 months12-month forecastHigh $40.00Average $40.00Low $40.00
PBLS peers
ETFs holding PBLS
Funds reporting this stock among their holdings, ordered by reported position size.
ETFMarket valueWeightAUMExpense ratioPrice / 1D
Vanguard Morningstar Total Stock Market ETFVTI38.09M0.00%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB27.5M0.01%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR8.73M0.01%68.3B USD0.05%$249.18+0.68%
Vanguard Morningstar Small-Cap Growth ETFVBK7.87M0.02%43.8B USD0.05%$358.65+0.70%
Fidelity Nasdaq Composite Index ETFONEQ1.11M0.01%10.35B USD0.21%$103.14+0.41%
Tema Healthcare AI ETFHLTH153.61K3.33%—0.00%$29.4417+1.87%
T. Rowe Price Innovation Leaders ETFTNXT11.76K0.06%——$28.5422-0.48%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 38.09M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 27.5M
- Weight
- 0.01%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 8.73M
- Weight
- 0.01%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
Vanguard Morningstar Small-Cap Growth ETFVBK- Market value
- 7.87M
- Weight
- 0.02%
- AUM
- 43.8B USD
- Expense ratio
- 0.05%
- Price / 1D
- $358.65+0.70%
Fidelity Nasdaq Composite Index ETFONEQ- Market value
- 1.11M
- Weight
- 0.01%
- AUM
- 10.35B USD
- Expense ratio
- 0.21%
- Price / 1D
- $103.14+0.41%
Tema Healthcare AI ETFHLTH- Market value
- 153.61K
- Weight
- 3.33%
- AUM
- —
- Expense ratio
- 0.00%
- Price / 1D
- $29.4417+1.87%
T. Rowe Price Innovation Leaders ETFTNXT- Market value
- 11.76K
- Weight
- 0.06%
- AUM
- —
- Expense ratio
- —
- Price / 1D
- $28.5422-0.48%
Continue in GoAI
Research PBLSresearch.disclaimer